# Post Operative Pain Control for Distal Radius Surgery: Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours ?

> **NCT04540848** · PHASE4 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** Group A (Exparel plus supraclavicular block)
- **DRUG:** Group B (Bupivacaine HCL plus supraclavicular block)
- **DRUG:** Group C(supraclavicular block only)

## Key facts

- **NCT ID:** NCT04540848
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-11-20
- **Final completion:** 2021-11-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of ability to communicate with the study population
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04540848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04540848, "Post Operative Pain Control for Distal Radius Surgery: Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours ?". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04540848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*